Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Mol Cell Cardiol. 2014 Nov 29;79:224–231. doi: 10.1016/j.yjmcc.2014.11.021

Figure 2.

Figure 2

EMAP II AB improved LV structure with reduced scar size and collagen deposition. (A) The scar size was decreased after EMAP II AB treatment for 4 weeks. Upper panels: Representative images of infarct rings after 4wk MI as shown by PSR staining; lower panel: quantitative data. (B) The interstitial fibrosis (%) in the adjacent area was less in the EMAP II AB group after both 1 and 4 week MI as shown by PSR staining. Upper panels: representative images after 1 wk MI; lower panel: quantitative data.